| Serial Number | 79313038 |
| Word Mark | HAEMATOKINE |
| Filing Date | Friday, February 5, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 23, 2022 |
| Registration Number | 6823077 |
| Registration Date | Tuesday, August 23, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 7, 2022 |
| Goods and Services | Pharmaceuticals, medical and veterinary preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Sanitary preparations for medical purposes; Stem cells for medical or veterinary use; Stem cells for medical purposes; Tumor suppressing agents; Pharmaceutical preparations, namely, antineoplastics; Anti-neoplastic preparations of chemical origin, namely, pharmaceutical preparations for hematological malignancies, bone marrow dysfunction or suppressions; Anti-neoplastic preparations of microbial origin, namely, pharmaceutical preparations for hematological malignancies, bone marrow dysfunction or suppressions; Anti-cancer preparations; Compounds for treating cancer, namely, anti-cancer preparations; Antibodies for medical purposes for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Antibodies for medical use to treat inflammation and cancer growth and spread; Adjuvants for medical purposes; Vaccine adjuvants; Biological adjuvants for medical purposes; Anti-inflammatories; Antigens, namely, tumour antigens for medical diagnostic purposes; Biological preparations for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical use, namely, biological preparations for the treatment of conditions associated with poor production of hematopoietic stem cells; Culture media for medical use, namely, culture media for use in augmentation of blood cells, bone marrow and tissues for medical purposes; Media for bacteriological cultures; Cell growth media for growing cells for medical use; Biological preparations for medical purposes, namely, biological preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Mixed biological preparations for medical purposes, namely, mixed biological preparations for the prevention and treatment of infectious diseases; Biological preparations for veterinary purposes, namely, biological preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical preparations, namely, immunomodulators; Immunostimulants; Injectable pharmaceuticals for treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of tumours; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances with anti-inflammatory properties for treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for use in hematology; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of disorders caused by bacteria; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for the prevention of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical products for the treatment of bone diseases; Regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes; Serotherapeutic medicines, namely, pharmaceutical preparations for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Synthetic peptides for pharmaceutical purposes for the treatment of hematological malignancies, bone marrow dysfunction or suppressions; Pharmaceutical products for treating respiratory diseases; Pharmaceutical compounds for treating respiratory diseases; Pharmaceutical preparations for treating respiratory diseases; Pharmaceutical compounds for treating correlated pulmonary syndromes; Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammation and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions; Pharmaceutical preparations for treatment and prevention of multi-organ failure, acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates |
| Goods and Services | Chemicals for use in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; Biological preparations for use in industry and science; Media for cell culture for use in the biotechnological industry, namely, cell culture media for scientific and research use; Media for cell culture for use in non-medical research laboratories, namely, cell culture media for laboratory use; Biological preparation for use in cell cultures other than for medical or veterinary use; Culture media for microbiology, for scientific and research use; Cell growth media for growing cells for scientific use; Biological preparation for use in cell cultures, other than for medical or veterinary use; Cultures of cell media other than for medical or veterinary use, namely culture media for scientific and research use; Cultures of microorganisms, other than for medical and veterinary use; Blood culture media being cell culture media for scientific use; Biological preparations for use in cell cultures, other than for medical or veterinary purposes; Stem cells, other than for medical or veterinary purposes; Stem cells for scientific purposes; Stem cells for research purposes |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, June 12, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, June 12, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Faron Pharmaceuticals Oy |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | FI |
| Party Name | Faron Pharmaceuticals Oy |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | FI |
| Party Name | Faron Pharmaceuticals Oy |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | FI |
| Event Date | Event Description |
| Wednesday, December 28, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, December 1, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, December 1, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 23, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 23, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 23, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 7, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 7, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 18, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, April 29, 2022 | ELECTRONIC RECORD REVIEW COMPLETE |
| Saturday, April 16, 2022 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, April 1, 2022 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, March 30, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 30, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 30, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 30, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 30, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, March 25, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 25, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 25, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 18, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, March 18, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, March 18, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, March 18, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, March 18, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, March 18, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, October 25, 2021 | REFUSAL PROCESSED BY IB |
| Monday, September 27, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, September 27, 2021 | REFUSAL PROCESSED BY MPU |
| Thursday, September 9, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, September 8, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, August 30, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, June 16, 2021 | APPLICATION FILING RECEIPT MAILED |
| Saturday, June 12, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, June 10, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |